Skip to main content

Table 1 Clinical characteristics of the patients

From: A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients

Characteristic

No. of patients

47

 

Age (year, mean ± SD)

73.6 ± 7.02

 

Initial PSA (median ± SD)

11.1 ± 489.1 ng/ml

 

Stage

No. of patients

 

T1cN0M0

8

17%

T2N0M0

14

29.8%

T3N0M0

9

19.1%

T4N0M0

2

4.3%

TanyN1M0

4

8.5%

TanyN0M1

5

10.6%

TanyN1M1

5

10.6%

Metastasis

 All distant metastasis

10

21.2%

 Bone metastasis

7

14.9%

 Visceral metastasis

3

6.4%

Gleason Score

 GS 6

4

9%

 GS 7

15

32%

 GS8

28

59%

  1. Abbreviations: PSA Prostate Specific Antigen